- Home
- / Paragon 28
Paragon 28
Stock Price
$5.2
2024-10-29
Market Capitalization
$433.6 M
2024-10-29
Revenue
$256.2 M
FY, 2024
Paragon 28 Summary
Company Summary
- Overview
- Paragon 28 is a medical device company focused on the foot and ankle orthopedic technologies. It offers plating systems, nails, screw systems, hammertoe implants, charcot systems, porous titanium wedges, total ankle replacement, Bun-Yo-Matic lapidus clamps, etc.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Englewood, CO, US | view all locations
- Website
- https://paragon28.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Frank Bono, Co-Founder, Chief Technology Officer
Matt Jarboe, Chief Commercial Officer
John Shumaker, Vice President of Sales - U.S.
LocationsView all
3 locations detected
Englewood, CO HQ
United States
14445 Grasslands Dr
Ada, MI
United States
519 Ada Dr SE #203
Dublin, D
Ireland
7 Beckett Way, Park West Business Park
Paragon 28 Financials
Summary Financials
- Revenue (FY, 2024)
- $256.2M
- Gross profit (FY, 2024)
- $191.5M
- Net income (FY, 2024)
- ($54.6M)
- Cash (FY, 2024)
- $34.6M
- EBIT (FY, 2024)
- ($40.8M)
- Enterprise value
- $509.7M